ARNA

Arena Pharmaceuticals, Inc. News Headlines

$4.62
*  
0.07
1.54%
Get ARNA Alerts
*Delayed - data as of Jan. 26, 2015  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARNA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Arena Pharmaceuticals Posts In Line Q3 Loss, Belviq Grows - Analyst Blog
11/4/2014 9:30:00 AM - Zacks.com


Orexigen's Contrave Has Modest Start
11/3/2014 1:30:00 PM - Seeking Alpha


Arena Beats The Street On Taigen Stock Sale
11/3/2014 1:26:00 PM - Seeking Alpha


Arena Says Phase 2 Trial For Lorcaserin Meets Primary Efficacy Endpoint
11/3/2014 8:06:00 AM - RTT News


Belviq Sales Recover From Holiday - Sales Flat In Q4 Thus Far
10/31/2014 4:51:00 PM - Seeking Alpha


Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected? - Analyst Blog
10/31/2014 2:34:00 PM - Zacks.com


Eisai Earnings Give Arena Investors Insights
10/31/2014 10:33:00 AM - Seeking Alpha


Arena Offers Tease On Belviq And Phentermine
10/29/2014 11:02:00 AM - Seeking Alpha


Belviq & Phentermine: A Diet Drug Cocktail In The Making?
10/29/2014 2:54:00 AM - RTT News


Belviq Sales Dip During Holiday Week, Should Show Steady Progress From Here
10/27/2014 7:38:00 AM - Seeking Alpha


Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads
10/22/2014 9:16:00 AM - Seeking Alpha


Arena Investors Need To Watch Contrave Launch Closely
10/22/2014 9:08:00 AM - Seeking Alpha


Could Arena Pharmaceuticals Inc. Be Running Out of Money?
10/22/2014 7:20:02 AM - Motley Fool


Orexigen Launches Contrave - Watch For Traction
10/20/2014 2:01:00 PM - Seeking Alpha


Belviq Sales Dip: What To Watch For Ahead
10/17/2014 1:13:00 PM - Seeking Alpha


What To Watch For As Orexigen's Launch Approaches
10/16/2014 8:05:00 AM - Seeking Alpha


Pfizer Setback Could Help Arena
10/15/2014 9:44:00 AM - Seeking Alpha


Belviq Sales Rise Almost 5% Week Over Week
10/10/2014 12:39:00 PM - Seeking Alpha


3 Biotech Stocks Near 52-Week Lows Worth Buying
10/8/2014 7:35:02 AM - Motley Fool


The 1 Biotech Stock I'm Definitely Not Buying
10/7/2014 7:35:04 AM - Motley Fool


Orexigen On A Tear - In The Wrong Direction
10/7/2014 1:10:00 AM - Seeking Alpha


Why Is Sanofi Betting on MannKind Corporation's Afrezza?
10/6/2014 9:29:48 AM - Motley Fool


Is VIVUS Inc. a Short Sell?
10/4/2014 12:45:02 PM - Motley Fool


Belviq Sales Flat - Model Your Expectations
10/3/2014 6:44:00 PM - Seeking Alpha


A Look At Arena's Other Drug
10/3/2014 4:37:00 PM - Seeking Alpha